Psilocybin integration

Neurofeedback for psilocybin integration.

A psilocybin session can open a door. What happens in the weeks afterward decides whether the change lasts. Psio gives those weeks structure, measurement, and a simple daily practice.

A window, not a switch

In mice, psilocybin increased connections between neurons in the frontal cortex within a day, and the change lasted at least a month [1]. A separate study found that psilocybin reopened a period of heightened social learning in mice that stayed open for about two weeks [2].

In people, a large clinical trial found that a single 25 mg dose of psilocybin improved treatment-resistant depression at three weeks, while the results for sustained response at twelve weeks were less clear [3]. The benefit is real, and holding onto it is the hard part.

What integration often looks like today

After a session, most clients have a handful of integration conversations with their facilitator or therapist. Those conversations matter. But in between them there is often little structure, and no objective way to see whether the change is holding.

How Psio adds structure

For facilitators and service centers

Psio fits inside the care you already provide. Your facilitators stay at the center of the work, and Psio adds a measured program around each session: a baseline during preparation, a recording around the session, and a daily practice for the weeks that follow. Clients see their own brain change, and your practice keeps the relationship well beyond the last dose.

Psio supports care alongside a client's provider. It is not a medical device and does not replace the guidance of a facilitator, therapist, or treatment team.

Get started with Psio

Clinics and facilitators can apply for early access. Individuals can start care now.

Not sure yet? Take the 2-minute assessment →
Devin Effinger, PhD

Psio was founded by Devin Effinger, PhD, a neuroscientist with a PhD in Neuropharmacology from UNC Chapel Hill and postdoctoral research on psilocybin and LSD at CU Anschutz.

Sources

  1. [1] Shao L-X, et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron, 2021 (summary from Yale University). Source
  2. [2] Nardou R, et al. Psychedelics reopen the social reward learning critical period. Nature, 2023 (summary from Johns Hopkins Medicine). Source
  3. [3] Goodwin GM, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine, 2022. Source

Keep reading